KPE 00001128
Alternative Names: KPE00001128Latest Information Update: 13 Mar 2008
At a glance
- Originator Kemin Pharma
- Class Antivirals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 13 Mar 2008 Discontinued - Preclinical for Herpes simplex virus infections in Belgium (unspecified route)
- 25 Mar 2004 Preclinical trials in Herpes simplex virus infections treatment in Belgium (unspecified route)